Gu, Stephanie http://orcid.org/0000-0002-6416-785X
Dusza, Stephen
Quigley, Elizabeth
Haliasos, Helen
Markova, Alina
Marchetti, Michael
Moy, Andrea P.
Dang, Chau
Modi, Shanu
Lake, Diana
Noor, Sarah
Lacouture, Mario E.
Article History
Received: 11 March 2023
Accepted: 25 September 2023
First Online: 13 October 2023
Declarations
:
: Alina Markova receives research funding from Incyte Corporation and Amryt Pharma; consults for ADC Therapeutics, Alira Health, Protagonist Therapeutics, OnQuality, and Janssen; and receives royalties from UpToDate. Mario E Lacouture has a consultant role with Johnson and Johnson, Novocure, Janssen, Novartis, Deciphera, Kintara, RBC/La Roche Posay, Trifecta, Genentech, Loxo, Seattle Genetics, Lutris, OnQuality, Roche, Oncoderm, Apricity. Mario E Lacouture also receives research funding from Lutris, Paxman, Novocure, OQL, Novartis and AZ, and is funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. Shanu Modi receives research funding from Genentech, Daiichi Sankyo, AstraZeneca, and Seattle Genetics. Shanu Modi also receives honoraria/consulting/advisory fees from Genentech, Daiichi Sankyo, AstraZeneca, Seattle Genetics, Gilead, Macrogenics, Novartis, GlaxoSmithKline, and Zymeworks. Chau Dang receives research support from Roche/Genentech and Puma, consulting support from Novartis, Pfizer and Seagen, and honorariums from Gilead and Daiichi. Elizabeth Quigley receives royalties from UptoDate.
: This is an observational study. The Memorial Sloan Kettering Cancer Center Research Ethics Committee has confirmed that no ethical approval is required. Informed consent was obtained from all participants in the study. The authors affirm that human research participants provided informed consent for publication of the images in Fig. InternalRef removed.